FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI
The basis for the approval was the successful results for deep-vein arterialization borne out in the PROMISE II trial.
Stay updated with breaking news from Surgical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The basis for the approval was the successful results for deep-vein arterialization borne out in the PROMISE II trial.
Carmen Solórzano, MD, FACS, of Vanderbilt University Medical Center, discusses how Vanderbilt-Ingram Cancer Center (VICC) conducts tumor boards and explains how patient preferences are considered during them.
Secretary of State for Science and Technology Michelle Donelan announced £13 million-worth of funding for 22 university-based projects to develop ...
The funding will support 22 projects spanning universities and NHS trusts across the UK.
Funding will support 22 projects spanning universities and NHS trusts across the UK